Radiotherapy for HPV-related cancers: prediction of therapeutic effects based on the mechanism of tumor immunity and the application of immunoradiotherapy.
CD8
CD8 based subtyping
Cervical cancer
Forkhead box P3
Human leukocyte antigen class I
Programmed death ligand 1
Radiotherapy
Tumor immunity
Journal
Japanese journal of radiology
ISSN: 1867-108X
Titre abrégé: Jpn J Radiol
Pays: Japan
ID NLM: 101490689
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
21
10
2021
accepted:
22
11
2021
pubmed:
2
1
2022
medline:
7
5
2022
entrez:
1
1
2022
Statut:
ppublish
Résumé
Human papillomavirus (HPV)-related cancer is one of the diseases entities for which the applications of radiotherapy have been increasing. Recently, the process of carcinogenesis from HPV infection and the mechanism of tumor immunity that develops during disease progression have been elucidated. In this review, we will describe the mechanism of tumor immunity and how chemoradiotherapy may overcome and improve the efficacy of tumor immunity. We will also discuss the usefulness of proteins involved with tumor immunity as a predictive marker of radiotherapy response, and present an overview of ongoing clinical trials of combinations of immune checkpoint inhibitors and radiotherapy to demonstrate the promising combination therapy that has been currently emerging.
Identifiants
pubmed: 34973113
doi: 10.1007/s11604-021-01231-4
pii: 10.1007/s11604-021-01231-4
pmc: PMC9068647
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
458-465Subventions
Organisme : Japan Society for the Promotion of Science
ID : 21K07680
Organisme : Japan Society for the Promotion of Science
ID : 21K07648
Informations de copyright
© 2021. The Author(s).
Références
Int J Biol Markers. 2020 Mar;35(1):65-73
pubmed: 31808707
Science. 1998 Apr 10;280(5361):243-8
pubmed: 9535647
Virus Res. 2017 Mar 2;231:166-175
pubmed: 27889616
J Pathol. 2014 Dec;234(4):431-5
pubmed: 25124771
Nat Rev Immunol. 2015 Jul;15(7):405-14
pubmed: 26027717
Int J Cancer. 2014 Jun 15;134(12):2755-63
pubmed: 23913554
Immunity. 2016 Mar 15;44(3):698-711
pubmed: 26982367
Nat Med. 2007 Sep;13(9):1050-9
pubmed: 17704786
Radiother Oncol. 2013 Sep;108(3):397-402
pubmed: 23830197
Oncoimmunology. 2015 Aug 31;5(3):e1086862
pubmed: 27141343
Exp Mol Pathol. 2019 Dec;111:104314
pubmed: 31654628
Sci Transl Med. 2013 Aug 28;5(200):200ra116
pubmed: 23986400
Oncoimmunology. 2017 Feb 6;6(3):e1288331
pubmed: 28405521
Jpn J Clin Oncol. 2020 Oct 22;50(11):1290-1297
pubmed: 33089868
J Hematol Oncol. 2016 May 27;9(1):47
pubmed: 27234522
Lancet Oncol. 2009 Jul;10(7):718-26
pubmed: 19573801
N Engl J Med. 2017 Nov 16;377(20):1919-1929
pubmed: 28885881
Radiother Oncol. 2018 Nov;129(2):409-414
pubmed: 30249348
Clin Cancer Res. 2016 Apr 15;22(8):1865-74
pubmed: 27084740
J Gynecol Oncol. 2016 Sep;27(5):e51
pubmed: 27329199
Cancer Res. 1996 Oct 1;56(19):4509-15
pubmed: 8813149
Cancer Res. 2009 Apr 1;69(7):3077-85
pubmed: 19293190
Ther Adv Med Oncol. 2018 Jan 18;10:1758834017742575
pubmed: 29383033
Cancer J. 2010 Jul-Aug;16(4):399-403
pubmed: 20693853
Nat Med. 2009 Oct;15(10):1170-8
pubmed: 19767732
Oncol Lett. 2021 Jun;21(6):446
pubmed: 33868484
Cancer Res. 2012 Aug 15;72(16):3967-76
pubmed: 22700877
Semin Cancer Biol. 2014 Jun;26:13-21
pubmed: 24316445
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2245-52
pubmed: 8637857
Trends Cancer. 2016 Jun;2(6):286-294
pubmed: 27774519
Med Mol Morphol. 2021 Sep;54(3):245-252
pubmed: 33963949
Vaccine. 2009 May 29;27 Suppl 1:A46-53
pubmed: 19480962
BMC Med. 2015 Mar 05;13:45
pubmed: 25857315
Sci Immunol. 2016 Sep;1(3):
pubmed: 28018989
Cell Mol Immunol. 2011 Jan;8(1):59-66
pubmed: 21200385
Allergy Asthma Clin Immunol. 2011 Nov 10;7 Suppl 1:S1
pubmed: 22165815
N Engl J Med. 2010 Jul 1;363(1):24-35
pubmed: 20530316
Nat Rev Clin Oncol. 2016 Mar;13(3):143-58
pubmed: 26598942
J Clin Oncol. 2011 Feb 20;29(6):610-8
pubmed: 21245428
Nat Rev Drug Discov. 2019 Mar;18(3):197-218
pubmed: 30610226
Cancer Immunol Immunother. 2007 May;56(5):739-45
pubmed: 17195077
J Immunol. 2002 Mar 15;168(6):2880-6
pubmed: 11884458
Immunity. 2013 Oct 17;39(4):782-95
pubmed: 24138885
Science. 2015 Apr 3;348(6230):69-74
pubmed: 25838375
Sci Rep. 2015 Oct 14;5:15179
pubmed: 26462617
Nat Rev Cancer. 2002 May;2(5):342-50
pubmed: 12044010
Nat Commun. 2017 Nov 24;8(1):1751
pubmed: 29170499
Strahlenther Onkol. 2020 Aug;196(8):725-735
pubmed: 31953603
Cancer Sci. 2007 Oct;98(10):1505-11
pubmed: 17645777
Vaccine. 2012 Nov 20;30 Suppl 5:F24-33
pubmed: 23199964
J Clin Oncol. 2004 Mar 15;22(6):1136-51
pubmed: 15020616
Mol Cancer. 2019 Jan 15;18(1):10
pubmed: 30646912
Oncotarget. 2014 Jan 30;5(2):403-16
pubmed: 24480782